Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · Real-Time Price · USD
18.55
+0.02 (0.11%)
Aug 6, 2026, 4:00 PM EDT - Market closed
Fulgent Genetics Revenue
Fulgent Genetics had revenue of $85.39M in the quarter ending June 30, 2026, with 4.38% growth. This brings the company's revenue in the last twelve months to $323.93M, up 6.83% year-over-year. In the year 2025, Fulgent Genetics had annual revenue of $322.67M with 13.83% growth.
Revenue (ttm)
$323.93M
Revenue Growth
+6.83%
P/S Ratio
1.58
Revenue / Employee
$246,336
Employees
1,315
Market Cap
510.41M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 322.67M | 39.20M | 13.83% |
| Dec 31, 2024 | 283.47M | -5.74M | -1.99% |
| Dec 31, 2023 | 289.21M | -329.76M | -53.27% |
| Dec 31, 2022 | 618.97M | -373.62M | -37.64% |
| Dec 31, 2021 | 992.58M | 570.87M | 135.37% |
| Dec 31, 2020 | 421.71M | 389.18M | 1,196.46% |
| Dec 31, 2019 | 32.53M | 11.18M | 52.35% |
| Dec 31, 2018 | 21.35M | 2.62M | 13.99% |
| Dec 31, 2017 | 18.73M | 454.00K | 2.48% |
| Dec 31, 2016 | 18.28M | 8.70M | 90.85% |
| Dec 31, 2015 | 9.58M | 8.30M | 649.30% |
| Dec 31, 2014 | 1.28M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Myriad Genetics | 806.60M |
| NeoGenomics | 766.30M |
| OPKO Health | 587.90M |
| CareDx | 458.09M |
| GeneDx Holdings | 454.43M |
| Castle Biosciences | 357.28M |
| Biodesix | 96.10M |
| Exagen | 71.12M |
FLGT News
- 3 days ago - Fulgent Genetics price target raised to $19 from $15 at Piper Sandler - TheFly
- 7 days ago - Fulgent Genetics reports Q2 adjusted EPS (58c), two estimates (44c) - TheFly
- 7 days ago - Fulgent Genetics cuts FY26 adjusted EPS view to ($2.35)-($2.22) from ($1.59) - TheFly
- 7 days ago - Fulgent Genetics Earnings Call Transcript: Q2 2026 - Transcripts
- 7 days ago - Fulgent Genetics Earnings release: Q2 2026 - Filings
- 7 days ago - Fulgent Genetics Slides: Q2 2026 - Filings
- 7 days ago - Fulgent Genetics Quarterly report: Q2 2026 - Filings
- 7 days ago - Fulgent Reports Second Quarter 2026 Financial Results - Business Wire